Clofibrate, pirinixil (BR 931) and WY-14,643 do not affect body cholesterol in Sprague-Dawley rats
- 1 November 1980
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 37 (3) , 475-483
- https://doi.org/10.1016/0021-9150(80)90154-9
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Increased plasma cholesterol and decreased body lipid levels in wistar rats following pirinixil (BR 931) treatmentPharmacological Research Communications, 1979
- Effect of wy-14,643 on cholesterol metabolism in normal and hypercholesterolemic ratsAtherosclerosis, 1978
- Pharmacological profile of BR-931, a new hypolipidemic agent that increases high-density lipoproteinsAtherosclerosis, 1978
- Studies with ethyl chlorophenoxyisobutyrate (clofibrate)Metabolism, 1965
- The effects of corn oil on the amounts of cholesterol and the excretion of sterol in the ratBiochemical Journal, 1961
- Standardization of hemoglobinometry II. The hemiglobincyanide methodClinica Chimica Acta; International Journal of Clinical Chemistry, 1961
- A simple method for the determination of serum cholesterolClinica Chimica Acta; International Journal of Clinical Chemistry, 1960
- THYROXINE ANALOGUES AND CHOLESTEROL METABOLISM: THE RELATIVE EFFECTS OF VARIOUS THYROXINE DERIVATIVES ON GROWTH, OXYGEN CONSUMPTION AND TISSUE CHOLESTEROL CONCENTRATIONS IN THE RATEndocrinology, 1960
- Diet and CholesteremiaJournal of Nutrition, 1959
- THYROXINE-LIKE COMPOUNDS AND CHOLESTEROL METABOLISM: DIFFERENCES IN THE EFFECTS OF THYROXINE, TRIIODOTHYRONINE AND THEIR FORMIC ACID ANALOGUES1Endocrinology, 1958